ABSTRACT
Cryptococcus neoformans is the etiologic agent of cryptococcosis, a lethal worldwide disease. Synthetic biology could contribute to its better understanding through engineering genetic networks. However, its major challenge is the requirement of accessible genetic parts. The database presented here provides 23 biological parts for this organism in Synthetic Biology Open Language.
ANNOUNCEMENT
Cryptococcus neoformans is a facultative intracellular basidiomycete fungus, which became an important human pathogen after the HIV/AIDS pandemic, mostly affecting immunocompromised patients (1–5). In 2014, the global incidence of cryptococcal meningitis was about 200,000 annually, resulting in around 180,000 annual deaths (6).
This medically important organism already had its genome sequenced (7), and several techniques that enable its genetic manipulation have also been developed (8). Even methods based on the recent gene editing system, CRISPR-Cas9, have been shown to be successful in C. neoformans (9–12). However, other synthetic biology tools, such as construction of genetic circuit networks that could advance the comprehension of its biology and pathogenicity, face constraints. One of the key points in this area is the standardization that supports description and characterization of the basic biological genetic parts such as promoters, terminators, and coding sequences (13). Recently, SynBioHub, a repository that allows researcher to exchange parts in Synthetic Biology Open Language (SBOL), was created (14), but those parts are not promptly available for nonmodel organisms.
Thus, the present study aimed to develop and make available to the scientific community an SBOL format database composed of successfully functionally evaluated genetic biological parts for C. neoformans.
Figure 1 describes the schematic strategy set to develop this study. Initially, a search in the literature was performed, using bibliographic databases such as PubMed and Google Scholar. The Biobricks terms used were promoters, coding sequences, terminators, and the organism’s name. From this, 9 articles were selected, and those were searched for whether the sequence was complete, whether the article contained the gene identifier (ID), or whether there was a genomic coordinate of the biological part. These 9 articles contained 15 parts, although 4 genetic parts from 3 articles were not admitted as they did not meet the verification criterion requirements, which were that the sequence is complete, it is functional, and it is in use in the target organism. The Addgene database was also searched using the same terms. There, 12 biological parts were found in 6 articles. In total, 12 articles for the 23 parts were accepted in this database, after a validation step through an alignment program, such as the Basic Local Alignment Search Tool, from NCBI followed by a search on FungiDB, UniProt, or Ensembl Fungi. Finally, these parts were deposited in SynBioHub, using SBOLDesigner3.1 (15, 16).
FIG 1.
Schematic representation of the strategy followed for Cryptococcus neoformans database assembly. At first a comprehensive evaluation of the literature for genetic biological parts from C. neoformans was performed in different bibliographic databases, such as PubMed and Google Scholar, with the following terms: promoters, coding sequences, terminators, and the target organism. In addition, the Addgene database was searched with the same terms. Only the genetic biological parts that met specific criteria such as the sequence being complete, being expressed, and being used in the target organism were selected for the following step. BLAST alignments were performed to confirm the genetic part sequence, followed by a search on FungiDB, UniProt, or Ensembl Fungi. Twenty-three parts from 12 articles were included in the database, and four genetic parts were excluded for not complying with the required criteria. The data were compiled in a table (https://doi.org/10.6084/m9.figshare.19990838.v2). The synthetic biology design tool, SBOLDesigner3.1, was used to create and to provide standardized visualizations of these individual genetic parts in the Synthetic Biology Open Language (SBOL), which were then deposited in the SynBioHub repository.
The table at figshare presents the information on each biological part that composes the C. neoformans database (https://doi.org/10.6084/m9.figshare.19990838.v2). The promoters were acquired from genes encoding actin (ACT1) (9), antiphagocytic protein (App1) (17), galactose kinase (GAL1) (18), galactose transferase (GAL7) (18, 19), UDP-glucose epimerase (UGE2) (18), glyceraldehyde-3-phosphate dehydrogenase (GPD) (20), U6 (CnU6) (10), orotidine monophosphate pyrophosphorylase (URA5) (21), and elongation factor 1 (TEF1) (9). The coding sequences were acetamidase (AmdS) (22), Cas9 (9, 23), the fluorescent protein mCherry (24), green fluorescent protein (GFP) (24), URA5 (21), hygromycin (HYG) (22, 25), neomycin (NEO/G418) (22, 26), and nourseothricin (NAT/NrsR) (24, 27) resistance genes. The terminators belonged to genes encoding phosphoribosylanthranilate isomerase (TRP1) (22), HOG1 (HOG1t) (24), TEF1 (9), CnU6 (10), and URA5 (21). In conclusion, the database is ready and accessible to all the community in the Synthetic Biology area.
Data availability.
Detailed information on the Cryptococcus neoformans database can be found at https://doi.org/10.6084/m9.figshare.19990838.v2 and in Synthetic Biology Open Language, which is available and can be accessed in SynBioHub by the following link: https://synbiohub.org/public/CnDatabase/CnDatabase_collection/1.
ACKNOWLEDGMENTS
We thank our supporting agencies, the Institutional Program of Scientific Scholarships, PIBIC, from the University of Brasilia, Brazil, and FAPDF (Research Support Foundation of the Federal District), Brazil.
C.M.C. conceived the study; S.G.R., A.C.C.B., and M.S.G. performed the data collection; S.G.R., A.C.C.B., L.H.S.P., and L.F.D.S. adapted the data to SBOL; S.G.R., A.C.C.B., I.S.-P. and C.M.C. wrote the manuscript. All the authors analyzed, revised, and discussed the data and contributed to the final paper.
We declare no conflict of interest.
Contributor Information
Ildinete Silva-Pereira, Email: xocolau@unb.br.
Cíntia Marques Coelho, Email: cintiacoelhom@unb.br.
Jason E. Stajich, University of California, Riverside
REFERENCES
- 1.Srikanta D, Santiago-Tirado FH, Doering TL. 2014. Cryptococcus neoformans: historical curiosity to modern pathogen. Yeast 31:47–60. doi: 10.1002/yea.2997. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 2.Kwon-Chung KJ, Fraser JA, Doering TL, Wang Z, Janbon G, Idnurm A, Bahn Y-S. 2014. Cryptococcus neoformans and Cryptococcus gattii, the etiologic agents of cryptococcosis. Cold Spring Harb Perspect Med 4:a019760. doi: 10.1101/cshperspect.a019760. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 3.Chen J, Varma A, Diaz MR, Litvintseva AP, Wollenberg KK, Kwon-Chung KJ. 2008. Cryptococcus neoformans strains and infection in apparently immunocompetent patients, China. Emerg Infect Dis 14:755–762. doi: 10.3201/eid1405.071312. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 4.Mesquita da Costa M, Martins Teixeira F, Ribeiro Schalcher T, Thielli Figueiredo Magalhães de Brito M, Silva Valerio E, Chagas Monteiro M. 2013. Cryptococcosis, a risk for immunocompromised and immunocompetent individuals. Open Epidemiol J 6:9–17. doi: 10.2174/1874297101306010009. [DOI] [Google Scholar]
- 5.Corrêa Pinheiro M, dos Reis DST, de Brito MTFM, Simões Quaresma JA. 2019. Cryptococcosis in the Amazon: a current overview and future perspectives. Acta Trop 197:105023. doi: 10.1016/j.actatropica.2019.05.014. [DOI] [PubMed] [Google Scholar]
- 6.Rajasingham R, Smith RM, Park BJ, Jarvis JN, Govender NP, Chiller TM, Denning DW, Loyse A, Boulware DR. 2017. Global burden of disease of HIV-associated cryptococcal meningitis: an updated analysis. Lancet Infect Dis 17:873–881. doi: 10.1016/S1473-3099(17)30243-8. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 7.Loftus BJ, Fung E, Roncaglia P, Rowley D, Amedeo P, Bruno D, Vamathevan J, Miranda M, Anderson IJ, Fraser JA, Allen JE, Bosdet IE, Brent MR, Chiu R, Doering TL, Donlin MJ, D’Souza CA, Fox DS, Grinberg V, Fu J, Fukushima M, Haas BJ, Huang JC, Janbon G, Jones SJM, Koo HL, Krzywinski MI, Kwon-Chung JK, Lengeler KB, Maiti R, Marra MA, Marra RE, Mathewson CA, Mitchell TG, Pertea M, Riggs FR, Salzberg SL, Schein JE, Shvartsbeyn A, Shin H, Shumway M, Specht CA, Suh BB, Tenney A, Utterback TR, Wickes BL, Wortman JR, Wye NH, Kronstad JW, Lodge JK, Heitman J, Davis RW, Fraser CM, Hyman RW. 2005. The genome of the basidiomycetous yeast and human pathogen Cryptococcus neoformans. Science 307:1321–1324. doi: 10.1126/science.1103773. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 8.Jung K-W, Lee K-T, So Y-S, Bahn Y-S. 2018. Genetic manipulation of Cryptococcus neoformans. Curr Protoc Microbiol 50:e59. doi: 10.1002/cpmc.59. [DOI] [PubMed] [Google Scholar]
- 9.Arras SDM, Chua SMH, Wizrah MSI, Faint JA, Yap AS, Fraser JA. 2016. Targeted genome editing via CRISPR in the pathogen Cryptococcus neoformans. PLoS One 11:e0164322. doi: 10.1371/journal.pone.0164322. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 10.Wang Y, Wei D, Zhu X, Pan J, Zhang P, Huo L, Zhu X. 2016. A ‘suicide’ CRISPR-Cas9 system to promote gene deletion and restoration by electroporation in Cryptococcus neoformans. Sci Rep 6:31145. doi: 10.1038/srep31145. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 11.Wang P. 2018. Two distinct approaches for CRISPR-Cas9-mediated gene editing in Cryptococcus neoformans and related species. mSphere 3:e00208-18. doi: 10.1128/mSphereDirect.00208-18. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 12.lin J, Fan Y, Lin X. 2020. Transformation of Cryptococcus neoformans by electroporation using a transient CRISPR-Cas9 expression (TRACE) system. Fungal Genet Biol 138:103364. doi: 10.1016/j.fgb.2020.103364. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 13.Lucks JB, Qi L, Whitaker WR, Arkin AP. 2008. Toward scalable parts families for predictable design of biological circuits. Curr Opin Microbiol 11:567–573. doi: 10.1016/j.mib.2008.10.002. [DOI] [PubMed] [Google Scholar]
- 14.McLaughlin JA, Myers CJ, Zundel Z, Mısırlı G, Zhang M, Ofiteru ID, Goñi-Moreno A, Wipat A. 2018. SynBioHub: a standards-enabled design repository for synthetic biology. ACS Synth Biol 7:682–688. doi: 10.1021/acssynbio.7b00403. [DOI] [PubMed] [Google Scholar]
- 15.McLaughlin JA, Beal J, Mısırlı G, Grünberg R, Bartley BA, Scott-Brown J, Vaidyanathan P, Fontanarrosa P, Oberortner E, Wipat A, Gorochowski TE, Myers CJ. 2020. The Synthetic Biology Open Language (SBOL) version 3: simplified data exchange for bioengineering. Front Bioeng Biotechnol 8:1009. doi: 10.3389/fbioe.2020.01009. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 16.Myers CJ. 2020. SBOLDesigner 3.1. https://github.com/SynBioDex/SBOLDesigner/releases/tag/v3.1.
- 17.Luberto C, Martinez-Mariño B, Taraskiewicz D, Bolaños B, Chitano P, Toffaletti DL, Cox GM, Perfect JR, Hannun YA, Balish E, Del Poeta M. 2003. Identification of App1 as a regulator of phagocytosis and virulence of Cryptococcus neoformans. J Clin Invest 112:1080–1094. doi: 10.1172/JCI18309. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 18.Ruff JA, Lodge JK, Baker LG. 2009. Three galactose inducible promoters for use in C. neoformans var. grubii. Fungal Genet Biol 46:9–16. doi: 10.1016/j.fgb.2008.10.003. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 19.Wickes BL, Edman JC. 1995. The Cryptococcus neoformans GAL7 gene and its use as an inducible promoter. Mol Microbiol 16:1099–1109. doi: 10.1111/j.1365-2958.1995.tb02335.x. [DOI] [PubMed] [Google Scholar]
- 20.Sun T-S, Ju X, Gao H-L, Wang T, Thiele DJ, Li J-Y, Wang Z-Y, Ding C. 2014. Reciprocal functions of Cryptococcus neoformans copper homeostasis machinery during pulmonary infection and meningoencephalitis. Nat Commun 5:5550. doi: 10.1038/ncomms6550. [DOI] [PubMed] [Google Scholar]
- 21.Edman JC, Kwon-Chung KJ. 1990. Isolation of the URA5 gene from Cryptococcus neoformans var. neoformans and its use as a selective marker for transformation. Mol Cell Biol 10:4538–4544. doi: 10.1128/mcb.10.9.4538. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 22.Erpf PE, Stephenson CJ, Fraser JA. 2019. amdS as a dominant recyclable marker in Cryptococcus neoformans. Fungal Genet Biol 131:103241. doi: 10.1016/j.fgb.2019.103241. [DOI] [PubMed] [Google Scholar]
- 23.Dicarlo JE, Norville JE, Mali P, Rios X, Aach J, Church GM. 2013. Genome engineering in Saccharomyces cerevisiae using CRISPR-Cas systems. Nucleic Acids Res 41:4336–4343. doi: 10.1093/nar/gkt135. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 24.So YS, Yang DH, Jung KW, Huh WK, Bahn YS. 2017. Molecular characterization of adenylyl cyclase complex proteins using versatile protein-tagging plasmid systems in Cryptococcus neoformans. J Microbiol Biotechnol 27:357–364. doi: 10.4014/jmb.1609.09036. [DOI] [PubMed] [Google Scholar]
- 25.Cox GM, Toffaletti DL, Perfect JR. 1996. Dominant selection system for use in Cryptococcus neoformans. J Med Vet Mycol 34:385–391. doi: 10.1080/02681219680000691. [DOI] [PubMed] [Google Scholar]
- 26.Hua J, Meyer JD, Lodge JK. 2000. Development of positive selectable markers for the fungal pathogen Cryptococcus neoformans. Clin Diagn Lab Immunol 7:125–128. doi: 10.1128/CDLI.7.1.125-128.2000. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 27.McDade HC, Cox GM. 2001. A new dominant selectable marker for use in Cryptococcus neoformans. Med Mycol 39:151–154. doi: 10.1080/mmy.39.1.151.154. [DOI] [PubMed] [Google Scholar]
Associated Data
This section collects any data citations, data availability statements, or supplementary materials included in this article.
Data Availability Statement
Detailed information on the Cryptococcus neoformans database can be found at https://doi.org/10.6084/m9.figshare.19990838.v2 and in Synthetic Biology Open Language, which is available and can be accessed in SynBioHub by the following link: https://synbiohub.org/public/CnDatabase/CnDatabase_collection/1.